Kidney disease as a risk factor for development of cardiovascular disease - A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention

被引：1525

作者：

Sarnak, MJ

Levey, AS

Schoolwerth, AC

Coresh, J

Culleton, B

Hamm, LL

McCullough, PA

Kasiske, BL

Kelepouris, E

Klag, MJ

Parfrey, P

Pfeffer, M

Raij, L

Spinosa, DJ

Wilson, PW

机构：

来源：

HYPERTENSION | 2003年 / 42卷 / 05期

关键词：

AHA Scientific Statements; kidney; cardiovascular diseases; risk factors;

D O I：

10.1161/01.HYP.0000102971.85504.7c

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：1050 / 1065

页数：16

共 188 条

[11]

BEATTIE JN, 2001, AM J KIDNEY DIS, V38, P701

[12] Impact of renal failure on the risk of myocardial infarction and death [J].

Beddhu, S ;

Allen-Brady, K ;

Cheung, AK ;

Horne, BD ;

Bair, T ;

Muhlestein, JB ;

Anderson, JL .

KIDNEY INTERNATIONAL, 2002, 62 (05) :1776-1783

[13] The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin [J].

Besarab, A ;

Bolton, WK ;

Browne, JK ;

Egrie, JC ;

Nissenson, AR ;

Okamoto, DM ;

Schwab, SJ ;

Goodkin, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (09) :584-590

[14] The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions [J].

Best, PJM ;

Lennon, R ;

Ting, HH ;

Bell, MR ;

Rihal, CS ;

Holmes, DR ;

Berger, PB .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (07) :1113-1119

[15]

BIGAZZI R, 1995, J HUM HYPERTENS, V9, P827

[16] Impact of aortic stiffness on survival in end-stage renal disease [J].

Blacher, J ;

Guerin, AP ;

Pannier, B ;

Marchais, SJ ;

Safar, ME ;

London, GM .

CIRCULATION, 1999, 99 (18) :2434-2439

[17] Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease [J].

Blacher, J ;

Pannier, B ;

Guerin, AP ;

Marchais, SJ ;

Safar, ME ;

London, GM .

HYPERTENSION, 1998, 32 (03) :570-574

[18] Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study [J].

Block, GA ;

Hulbert-Shearon, TE ;

Levin, NW ;

Port, FK .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 31 (04) :607-617

[19] Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis [J].

Boaz, M ;

Matas, Z ;

Biro, A ;

Katzir, Z ;

Green, M ;

Fainaru, M ;

Smetana, S .

KIDNEY INTERNATIONAL, 1999, 56 (03) :1078-1083

[20] Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial [J].

Boaz, M ;

Smetana, S ;

Weinstein, T ;

Matas, Z ;

Gafter, U ;

Iaina, A ;

Knecht, A ;

Weissgarten, Y ;

Brunner, D ;

Fainaru, M ;

Green, MS .

LANCET, 2000, 356 (9237) :1213-1218

← 1 2 3 4 5 6 7 8 9 10 →